Reckitt Benckiser Group plc

As of December 31, 2025, Reckitt Benckiser Group plc carries a market capitalization of 896.42B, placing it among publicly traded companies globally. Its enterprise value stands at 1.06T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Reckitt Benckiser Group plc's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2025, Reckitt Benckiser Group plc has 647.09M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Reckitt Benckiser Group plc maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on June 30, 2026, Reckitt Benckiser Group plc's stock has declined approximately 23.54% over the past 52 weeks. The 50-day moving average sits at 1,200.82, while the 200-day moving average is 1,553.29.

As of December 31, 2025, Reckitt Benckiser Group plc holds 42.93B in cash and equivalents against 204.48B in total debt, resulting in a net debt position of 154.90B. Total book value stands at 187.89B, with working capital of -24.62B providing operational flexibility.

Reckitt Benckiser Group plc's most recent stock split took place on February 2, 2026 with a 25:24 split ratio.